Cytochrome P450 expression and catalytic activity in coronary arteries and liver of cattle

被引:21
|
作者
Grasso, E
Longo, V
Coceani, F
Gervasi, PG
机构
[1] CNR, Inst Clin Physiol, I-56127 Pisa, Italy
[2] Scuola Super Sant Anna, Pisa, Italy
来源
关键词
cytochrome P450; cattle; coronary artery; liver; vasoregulation; metabolism of xenobiotic;
D O I
10.1016/j.bbagen.2004.11.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is increasing evidence that cytochrome P450 (CYP) enzymes are involved not only in the metabolism of xenobiotics, but also in vascular homeostasis. Among the CYP-derived vasoactive agents, special importance is assigned to endogenous products from arachidonic acid (AA). Specifically, the vasodilator epoxyeicosatrienoic acids (EETs), being linked to the CYP 2B, 2C, and 2J subfamilies, and the vasoconstrictor 20-hydroxyeicosatetraenoic acid (20-HETE) connected instead to the CYP 4A subfamily and, to a lesser degree, to isoforms of the CYP 1A and 2E subfamilies. Here, we have examined the occurrence of functional CYP isoforms in the coronary arteries of cattle by RT-PCR with sequence verification, Western immunoblotting, and analysis of distinct catalytic activities with fluorescent substrate probes. Liver tissue was examined comparatively. Coronary tissue expressed mRNA transcripts and immunoreactive proteins belonging to the CYP 1A, 2C, 2E, and 2J subfamilies. Appropriate catalytic activity was ascertained with all these CYP species except 2J. A broader spectrum of CYP enzymes (CYP 1A, 2B, 2C, 2D, 2E, 2J, 3A, 4A subfamilies) was found in liver tissue with catalytic activities exceeding many fold those of coronary tissue. We conclude that bovine coronary arteries are endowed with a full-fledged CYP system with potential for AA-linked vasoregulation through dilator rather than constrictor agents. The same tissue and, to a much larger degree, liver tissue possess the capability of metabolizing xenobiotics via the CYP pathway. (c) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:116 / 123
页数:8
相关论文
共 50 条
  • [41] Expression and inducibility of cytochrome P450 proteins in the liver of chick embryo
    Machala, M
    Nezveda, K
    Irizar, A
    BuAbbas, A
    Icannides, C
    ARCHIVES OF TOXICOLOGY, 1996, 71 (1-2) : 57 - 63
  • [42] Catalytic and immunochemical characterization of cytochrome P450 isozyme induction in dog liver
    Jayyosi, Z
    Muc, M
    Erick, J
    Thomas, PE
    Kelley, M
    FUNDAMENTAL AND APPLIED TOXICOLOGY, 1996, 31 (01): : 95 - 102
  • [43] Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver
    Lindros, KO
    GENERAL PHARMACOLOGY, 1997, 28 (02): : 191 - 196
  • [44] Influence of brain dopaminergic system on cytochrome P450 activity in the liver
    Wojcikowski, J
    Golembiowska, K
    Daniel, WA
    PHARMACOLOGICAL REPORTS, 2006, 58 (02) : 312 - 313
  • [45] Effects of Hispidulin on the Activity of Human Liver Cytochrome P450 Enzymes
    Xiang, Tinghai
    Xu, Huaiyong
    Yan, Wenyan
    Song, Dekun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (09): : 2036 - 2042
  • [46] Effects of Hispidulin on the Activity of Human Liver Cytochrome P450 Enzymes
    Xiang, Tinghai
    Xu, Huaiyong
    Yan, Wenyan
    Song, Dekun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2019, 38 (01): : 57 - 62
  • [47] Effects of catalpol on the activity of human liver cytochrome P450 enzymes
    Liu, Lu
    Cao, Xiangang
    Li, Tingxin
    Li, Xiaohua
    XENOBIOTICA, 2019, 49 (11) : 1289 - 1295
  • [48] Reduced Duodenal Cytochrome P450 3A Protein Expression and Catalytic Activity in Patients With Cirrhosis
    McConn, D. J., II
    Lin, Y. S.
    Mathisen, T. L.
    Blough, D. K.
    Xu, Y.
    Hashizume, T.
    Taylor, S. L.
    Thummel, K. E.
    Shuhart, M. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (04) : 387 - 393
  • [50] Taurine modulates catalytic activity of cytochrome P450 3A4
    Shumyantseva, V. V.
    Makhova, A. A.
    Bulko, T. V.
    Bernhardt, R.
    Kuzikov, A. V.
    Shich, E. V.
    Kukes, V. G.
    Archakov, A. I.
    BIOCHEMISTRY-MOSCOW, 2015, 80 (03) : 366 - 373